Delivery Order SPE2DB22D2007-SPE2DB25FJ5KA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $66,709.27, was competitively awarded with no set-aside designation and is scheduled for completion by August 19, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $36,293.07. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract is valued at $59,442.23 and carries a firm fixed price structure with completion scheduled for September 11, 2025. The delivery order was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 tablets per unit. This competitively awarded, firm fixed-price delivery order has a ceiling value of $17,461.55 and an ultimate completion date of September 17, 2025. The contract carries no set-aside designation, indicating it was competed among all eligible vendors. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units) with a ceiling value of $220,407.12. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order valued at $46,472.02 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by April 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive, non-set-aside contract carries a ceiling value of $29,348.41 and features firm fixed pricing, with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitive award, valued at $11,159.05 under a firm fixed-price contract type, is scheduled for completion by August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $6,642.35. This is a firm fixed price delivery order with an ultimate completion date of September 29, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $82,073.02 on September 16, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5KADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $36.7K with a firm fixed price structure and an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills this delivery order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to compete successfully across the federal medical supply market, combined with its substantial prime vendor relationship with DLA, positions it to continue fulfilling critical pharmaceutical needs across multiple therapeutic domains in support of military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.7k | 9/26/25 |